Similarly, exosomal circUSP7 derived from NSCLC cells induces resistance to anti‐PD1 immunotherapy by promoting CD8+ T cell dysfunction in NSCLC, providing a rationale for improving anti‐PD1 treatment efficacy in NSCLC [37]. Here, CD8A is linked to non-small cell lung carcinoma.